Published by Josh White on 13th April 2022
(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Wednesday that a milestone equity payment has been triggered, resulting in an increase in its shareholding in AffyXell Therapeutics.
URL: http://www.digitallook.com/dl/news/story/32605014/...